ライフサイエンスコーパス: prevalence rate

1 calculated by calibrating against real-world prevalence rates.

2 0), comparable with our previously published prevalence rates.

3 s, thus potentially leading to overestimated prevalence rates.

4 ods to determine country-specific pooled CHB prevalence rates.

5 panzees, can be infected with SIVcpz at high prevalence rates.

6 ulations can be infected with SIVcpz at high prevalence rates.

7 es provided data enabling a meta-analysis of prevalence rates.

8 ially in TB-endemic countries with rising DM prevalence rates.

9 since onset was estimated from age-specific prevalence rates.

10 nconsistent among regions with different HCV prevalence rates.

11 s of visual impairment for regions with high prevalence rates.

12 1434 SSIs after 132,111 surgical procedures (prevalence rate = 1.09/100 procedures).

13 5 lung transplant recipients developed IFIs (prevalence rate, 19.1 IFIs per 100 surgeries, 95% confid

14 , respectively; difference between groups in prevalence rates, 22.7% [95% CI, 16.4%-28.9%]) and at th

15 among whom 4725 had biopsy-proven cirrhosis (prevalence rate, 24%; 95% CI, 20%-28%).

16 g YMRS items) yielded lower mixed depression prevalence rates (6.3% and 10.8% of visits, respectively

17 There was also a significant increase in the prevalence rate (8 to 17 per 100 000 person-years) and i

18 ysical function prior to pneumonia (adjusted prevalence rates, 91.7 vs 65 cases per 1,000 person-year

19 al Health Survey initiative provides us with prevalence rate across 11 countries, while several meta-

20 Age-standardized prevalence rates across studies were estimated using the

21 ascertain the trends in modern contraceptive prevalence rates among all women aged 15-49 years and al

22 ual rates of changes in modern contraceptive prevalence rates among all women of reproductive age (15

23 12.5), and 12 autoimmune diseases had higher prevalence rates among parents of schizophrenia patients

24 cystitis, and Sjogren's syndrome had higher prevalence rates among patients with schizophrenia than

25 Nine autoimmune disorders had higher prevalence rates among patients with schizophrenia than

26 Significantly higher prevalence rates among prisoners as compared to the gene

27 Tanzania, Uganda, and Kenya with high HIV-1 prevalence rates among the populations examined.

28 The present investigation aims to study the prevalence rate and clinical characteristics of CD among

29 f data came from the National Survey for STD Prevalence Rate and Sexual Behavior of the High-Risk Sex

30 study was the analysis of clinical symptoms, prevalence rate and the most common concurrent central n

31 The parasite prevalence rates and age-specific seroconversion rates (

32 y highlighting the need for policy to reduce prevalence rates and ameliorate rising levels of NCDs.

33 Recent studies have investigated prevalence rates and associated factors.

34 Confidence intervals for the estimated CHD prevalence rates and case counts were derived from a com

35 We estimated VI and blindness prevalence rates and confidence intervals for each surve

36 orders remains controversial, with detection prevalence rates and immunoglobulin classes varying cons

37 The prevalence rates and influencing factors for deployment

38 Yet estimated prevalence rates and patterns remain tenuous because mea

39 uctural models, we calculated model-adjusted prevalence rates and ratios to determine characteristics

40 uctural models, we calculated model-adjusted prevalence rates and ratios to determine the characteris

41 in malaria exposure was detected by parasite prevalence rates and SCR estimates for samples of health

42 We compared prevalence rates and temporal trends in CHD subtypes bef

43 reciation of previously underestimated PIDs' prevalence rates and the delay in their diagnosis.

44 first 180 days after transplant, we analyzed prevalence rates and timing of IFIs, risk factors for IF

45 Conversely, prevalence rates and titers to AdC6 and AdC7 were marked

46 IPF incidence and prevalence rates are increasing annually with few effect

47 Overall prevalence rates are lower than reported in other LMICs.

48 ocation, we used cross-tabulations to assess prevalence rates as a function of the decade of the init

49 Persistent or increased prevalence rates at 12 months compared with 3 months pos

50 HIV and hepatitis C virus prevalence rates at one HDU 1 (5.7% and 6.5%, respective

51 of AHI were calculated for programs with HIV prevalence rates between 0.1% and 2.9%.

52 prevalence of H. pylori approaches 50%, with prevalence rates between 20 and 40% in developed countri

53 or males and females to study differences in prevalence rates between HIV-positive and HIV-negative i

54 No differences were found in lifetime prevalence rates between migrant and U.S.-born Puerto Ri

55 There was considerable heterogeneity in prevalence rates between studies; for late AMD, 20% of t

56 Data from children suggest a similar prevalence rate, but lower prevalence rates of usage wer

57 Prevalence rates by indication, site, and catheter type

58 The data were pooled and prevalence rates calculated.

59 Reconstructed smoking prevalence rates compared with contemporary measured rat

60 Sampling weights were used to calculate prevalence rates, confidence intervals, and statistical

61 ts were calculated by applying incidence and prevalence rates derived from Surveillance, Epidemiology

62 nmental clues with higher multiple sclerosis prevalence rates; dietary vitamin supplementation is als

63 United States are colonized with S. aureus; prevalence rates differ demographically.

64 global burden of HF continues to rise, with prevalence rates estimated at 1-2% and incidence approac

65 ity and eventual morbidity cases with stable prevalence rates, even with treatment by the on-going mu

66 y and, by the end of adolescence, the 1 year prevalence rate exceeds 4%.

67 Modeled prevalence rates exhibited substantial variation across

68 We detected a 3% prevalence rate for human parechovirus (HPeV) in 720 res

69 The overall prevalence rate for hypertension was 35.5% according to

70 The minimum prevalence rate for mtDNA mutations was 1 in 5,000 (20 p

71 The pooled prevalence rate for overall elder abuse was 15.7% (95% C

72 The annual prevalence rates for 2006 and 2007 were 57.5 and 58.0 pe

73 Lifetime prevalence rates for all three disorders were higher in

74 These factors included county prevalence rates for asthma in children and adults, chro

75 and epidemiological factors (extremely high prevalence rates for childhood physical and sexual abuse

76 have used structured interviews to establish prevalence rates for clinical mood disorders in SSc, alt

77 Prevalence rates for CSA are difficult to obtain.

78 subfield thickness (CST) can yield different prevalence rates for DME.

79 We reconstructed smoking prevalence rates for each calendar year from 1940 to 200

80 nual rate of changes in modern contraceptive prevalence rates for each country setting from the avera

81 high-intensity warfare and chemical weapons, prevalence rates for lifetime PTSD, current PTSD, major

82 Three-month prevalence rates for meeting criteria for disruptive moo

83 The pooled prevalence rates for mental disorders among FSWs in LMIC

84 The acute kidney injury prevalence rates for normal, overweight, class I, II, an

85 onization of livestock animals is common and prevalence rates for pigs have been reported to be as hi

86 The standardised prevalence rates for Poser probable/definite MS per 100,

87 Prevalence rates for prospective specimens were 7.3%, 4.

88 this population, the estimated pooled 1 year prevalence rates for psychosis were 6.2% (95% CI 4.0-8.6

89 Prevalence rates for PTSD or depression with serious fun

90 Prevalence rates for resistance to PT, CE, and ME were 2

91 Year-round prevalence rates for serum 25(OH)D concentrations <30, <

92 Our study found high prevalence rates for symptoms of PTSD and depression in

93 view Survey (NHIS) to estimate incidence and prevalence rates for the overall civilian, noninstitutio

94 ulated trends in both crude and standardized prevalence rates for the Rose questionnaire on angina (s

95 rvey results and NHANES physical evaluation, prevalence rates for VI increased significantly with inc

96 2 annual growth rate of modern contraceptive prevalence rates from an estimated 0.7 to 1.4 percentage

97 The prevalence rates from NAFLD were 40.3% (95% CI: 37.2-43.

98 Prevalence rates from selected population-based studies

99 With prevalence rates globally increasing, this condition is

100 ) for similar populations of MSM with an HIV prevalence rate >0.4%; Architect was the second best alt

101 so among similar populations of MSM with HIV prevalence rates >0.4%.

102 tect was the second best alternative for HIV prevalence rates >0.6%.

103 d in Aberdeen, Orkney and Shetland to see if prevalence rates had changed, assess which factors affec

104 , few health-sector donors, and high disease-prevalence rates had higher evaluation scores.

105 failure (HF) mortality, hospitalization, and prevalence rates has been observed among older persons i

106 Previously reported prevalence rates have been widely variable based on the

107 Dementia is a global issue, with increasing prevalence rates impacting on health services internatio

108 The lowest prevalence rate in the last period analyzed was observed

109 nnual rate of change in modern contraceptive prevalence rates in all women across all nine settings w

110 12 for research reporting metabolic syndrome prevalence rates in bipolar patients.

111 el Disease (IBD) with its high incidence and prevalence rates in Canada generates a heavy burden of t

112 Despite dropping prevalence rates in developed nations, most new Helicoba

113 ) is a frequent anxiety disorder with higher prevalence rates in female patients than in male patient

114 ling to define age-specific and sex-specific prevalence rates in HIC and in LMIC and combined them wi

115 e post-Summit trends in modern contraceptive prevalence rates in nine settings in eight sub-Saharan A

116 troglodytes apes in southern Cameroon, where prevalence rates in some communities reached 29 to 35%.

117 To compare disability prevalence rates in the major ethnic groups in the UK an

118 Scotland had the highest incidence and prevalence rates in the UK.

119 One allele was associated with lower SIVcpz prevalence rates in the wild.

120 fection prevalence may be related as much to prevalence rates in women's areas of origin or exploitat

121 Sex-specific prevalence rates increased with age and were broadly sim

122 instruments are available, and the estimated prevalence rate is 7% of bereaved people.

123 tzerland, where it is estimated that the HCV prevalence rate is between 5.7% and 6.2%.

124 and projections of the modern contraceptive prevalence rate (mCPR), unmet need for, and demand satis

125 Lipomas are benign fatty tumors with a high prevalence rate, mostly found in adults but have a good

126 Prevalence rates obtained with nested PCR were significa

127 ed as having a Grade >/= 1 pressure ulcer, a prevalence rate of 0.40 per 1000 adults.

128 ed as having a pressure ulcer Grade >/= 1, a prevalence rate of 0.77 per 1000 adults.

129 December 31, 2014), corresponding to a crude prevalence rate of 10.54 per 100 000 population (95% CI,

130 With an overall prevalence rate of 20.6% in our study population, deliri

131 nic culture method (reference method), for a prevalence rate of 20.7%.

132 impanzees were SIVcpz infected, indicating a prevalence rate of 31% (95% confidence interval, 21% to

133 s common among this study population, with a prevalence rate of 32.8%.

134 northern Italy reveal a post-entry screening prevalence rate of 535 per 100000 individuals screened.

135 were detected in subgingival samples, with a prevalence rate of 72.2%, 47.2%, 74.3%, and 82.9%, respe

136 dystrophy, for an overall corneal dystrophy prevalence rate of 897 per million (10(6)) covered lives

137 The prevalence rate of APOE-epsilon4 was higher in the high-

138 esults from studies showed that the lifetime prevalence rate of bipolar II disorder in adults across

139 The overall birth prevalence rate of CHDs was 12.3 per 1000 total births.

140 ime period and applied an assumed population prevalence rate of food allergy.

141 The prevalence rate of H. pylori infection in the 164 patien

142 The prevalence rate of infection ranged between 0 and 86% pe

143 The prevalence rate of invasive candidiasis (IC) was 11.4% (

144 using Affymetrix microarrays showed that the prevalence rate of OGG1 expression was 33% and correlate

145 The low prevalence rate of orphan diseases (OD) requires special

146 The study found the prevalence rate of PED, corneal ulceration, and corneal

147 The prevalence rate of pneumothorax recorded was 0.4%, and a

148 The prevalence rate of reflux esophagitis (RE) in Asia, incl

149 (EGPA) is a rare systemic vasculitis with a prevalence rate of seven per million.

150 The 3-year prevalence rate of suicide attempt was 0.6% (n = 241).

151 help to advance progress toward lowering the prevalence rate of tobacco use in the U.S. and lowering

152 The prevalence rates of 25(OH) Vitamin D(3) deficiency and i

153 nce of dietary supplement usage of 40%, with prevalence rates of 35% in NHANES II and 23% in NHANES I

154 The high prevalence rates of adenomas were accounted for by detec

155 Prevalence rates of AERD ranged from 5.5% to 12.4% based

156 One-year prevalence rates of alcohol abuse (2.3% vs. 3.9%; Z=-2.0

157 Elevated lifetime prevalence rates of alcohol use disorders (AUDs) are a f

158 study outcomes were long-term incidence and prevalence rates of ALS using a prospective design and t

159 Prevalence rates of anemia, iron deficiency, and iron de

160 Incidence and prevalence rates of antidepressant prescriptions in each

161 Despite cross-site variation in the prevalence rates of BPS, the severity, impact, and patte

162 The prevalence rates of C. trachomatis and N. gonorrhoeae by

163 The prevalence rates of C. trachomatis and N. gonorrhoeae in

164 The incidence and prevalence rates of cardiac amyloidosis among hospitaliz

165 Conclusions The incidence and prevalence rates of cardiac amyloidosis are higher than

166 ally, sub-Saharan Africa has had the highest prevalence rates of clinically detected rheumatic heart

167 hospital days, antibiotic exposures, and the prevalence rates of Clostridium difficile, methicillin-r

168 ation of cannabis and NTPs, despite the high prevalence rates of co-use in adolescence.

169 ed with a favorable metabolic profile, lower prevalence rates of comorbidities (arterial hypertension

170 Although prevalence rates of comorbidity decreased in youth after

171 The prevalence rates of corneal ulcer and perforation were 6

172 nts, black and Hispanic patients have higher prevalence rates of diabetes mellitus and chronic renal

173 Little is known about prevalence rates of DSM-IV disorders across age strata o

174 Prevalence rates of DSM-IV mental and substance use diso

175 Prevalence rates of DSM-IV mood and anxiety disorders in

176 e, and race have a significant effect on the prevalence rates of early and late AMD (P < .001).

177 eta-analysis for each condition to determine prevalence rates of extrahepatic manifestations of HCV i

178 Prevalence rates of FGID are high.

179 Prevalence rates of FGID in our sample were similar to t

180 iagnosis of FGID has consequences for actual prevalence rates of FGID.

181 erage, a decrease of 38.51% was found in the prevalence rates of FGID.

182 The prevalence rates of gallstones were 80% in wild-type and

183 The prevalence rates of HDV infection were 74.9%, 43.9%, 11.

184 The prevalence rates of hypertension, atrial fibrillation, a

185 Prevalence rates of hypertension, diabetes mellitus, CKD

186 The overall extrapolated prevalence rates of IBD were 0.32% in 2010, 0.38% in 201

187 os (ORs) for injuries and the mean change in prevalence rates of injuries and emergency ward visits b

188 month, 1-year, and lifetime age-standardized prevalence rates of itchy rash that lasted longer than 3

189 No sex differences in prevalence rates of large drusen or late AMD were observ

190 ributing to the persistent carriage and high prevalence rates of livestock-associated methicillin-res

191 issive but little is known about whether the prevalence rates of marijuana use and marijuana use diso

192 Several years after the end of the war, the prevalence rates of mental disorders among war-affected

193 The present study aimed to establish prevalence rates of mental disorders in Chilean prisoner

194 opulations in LMICs might have overestimated prevalence rates of mental disorders.

195 The prevalence rates of MetS and RE were respectively 28.5 a

196 This study sought to study the prevalence rates of modifiable RFs during a first AMI, s

197 Prevalence rates of mood, anxiety, and substance use dis

198 Although prevalence rates of most psychiatric disorders declined

199 The prevalence rates of Mycoplasma genitalium infections and

200 The prevalence rates of parent-reported LD, ADHD, and both L

201 e of this study is to compare the population prevalence rates of past-year male-perpetrated IPV and n

202 rch was conducted in multiple databases, and prevalence rates of patients (>75 years) were pooled.

203 The prevalence rates of patients with minimum clinically imp

204 Prevalence rates of PE, hypertension, multiple gestation

205 The prevalence rates of personal history with allergic proct

206 Prevalence rates of persons identifying as transgender a

207 gistry were used to calculate the real-world prevalence rates of PHM and mCNV among patients with HM

208 We report incidence and prevalence rates of physical and mental health disorders

209 Lifetime, 6-month, and 12-month prevalence rates of physical and sexual violence among i

210 Prevalence rates of positive depression status were 24.4

211 se studies in Mexico and Barbados, where the prevalence rates of protective HLA alleles are 8% and 34

212 ulation-based cohorts, because incidence and prevalence rates of PSC are markedly lower and survival

213 The prevalence rates of PTSD and depression after returning

214 Autopsy studies show the uniquely high prevalence rates of small, indolent tumors in men dying

215 Sex-specific and age-adjusted incidence and prevalence rates of STDR were analyzed for patients with

216 The age-adjusted prevalence rates of STDR were in decreasing trends for b

217 Apart from apparent sex differences in prevalence rates of STDR, increasing trends were observe

218 ombining the relative risks and the observed prevalence rates of the risk factors of interest.

219 However, studies have shown varying prevalence rates of these disorders based on different c

220 tribute to explaining sex differences in the prevalence rates of this childhood disorder.

221 Relatively high prevalence rates of this syndrome (15%) were recorded at

222 stence in the MGT may contribute to the high prevalence rates of transmitted drug resistance.

223 suggest a similar prevalence rate, but lower prevalence rates of usage were reported in studies of ad

224 Prevalence rates of VI and blindness obtained from natio

225 The sample-weighted prevalence rates of WCH and MH were 3.3% and 17.8%, resp

226 This is the first study to document the prevalence, rate of progression, and factors associated

227 We investigated the prevalence, rate of progression, and independent predict

228 or longitude, and crude or age-standardized prevalence rates, of early and late AMD (P < .001).

229 st frequently implicated genes overall (with prevalence rates per families) were as follows: ABCA4 (2

230 Plasmodium falciparum prevalence rate (PfPR) in children 0.5-14 y old (primary

231 h approach across a range of hypothetical RT prevalence rates plausible for the United States.

232 Prevalence rates predicted by the model strongly agree w

233 ness of PrEP is sensitive to the initial HIV prevalence rate, PrEP and antiretroviral therapy (ART) a

234 gnostic Interview (CIDI) and compared to the prevalence rates previously published for the general po

235 Prevalence rates, race and sex differences, and temporal

236 Prevalence rates ranged from 2.2% at CT to 15.9% at MR i

237 es had been implemented, anti-Ov-16 antibody prevalence rates ranged from 5.2% to 65.1%.

238 lth care sites across the United States with prevalence rates ranging from 5.2% to 44%.

239 s compared with normal BMI persons (Adjusted Prevalence Rate Ratio (APRR) 1.9, 95%CI 1.3-2.8).

240 was almost twice as high at small hospitals [prevalence rate ratio (PRR) = 1.9 (95% CI 1.78-2.05)] an

241 vs 65 cases per 1,000 person-years; adjusted prevalence rate ratio = 1.6; CI, 1.06-2.7; p = 0.03).

242 in the frequency of pregnancy loss (adjusted prevalence rate ratio [aPRR] 1.19, P = .8) or neonatal d

243 er HIV prevalence (10.2% vs. 22.0%; adjusted prevalence rate ratio [PRR], 0.49 [95% confidence interv

244 n each disease category, as well as overall (prevalence rate ratio, 1.15; 95% CI, 1.13-1.17; p < 0.00

245 The authors calculated adjusted prevalence rate ratios (PRRs) with 95% confidence interv

246 Prevalence rate ratios and 95% confidence intervals were

247 We used Poisson models to estimate prevalence rate ratios, comparing 2011 and 2016 antibiot

248 Orkney has the highest prevalence rate recorded worldwide.

249 n preschool sample, which is comparable with prevalence rates reported by other recent studies in pre

250 These estimated prevalence rates represent substantial increases over th

251 Our findings suggest that the SFTS prevalence rate rose since 2010 and reached its highest

252 nce was higher than local general population prevalence rates (RR: 2.09; 95% CI 1.39 to 2.95 and RR:

253 ary lipid secretion rates and high gallstone prevalence rates similar to WT mice without any elevatio

254 escent population of Northwest China and its prevalence rates substantially vary with weight status a

255 Pacific Islanders had a lower prevalence rate than non-Pacific Islanders (2006: P = .0

256 = .04), while white individuals had a higher prevalence rate than nonwhite individuals (2006: P = .07

257 vident throughout the European population at prevalence rates that are concerning and that require ac

258 risk alleles are nonetheless represented at prevalence rates that bespeak an adaptive function.

259 various intervals of treatment for different prevalence rates, there has been a lack of sufficient fo

260 The reconstruction of smoking prevalence rates through this methodology offers a feasi

261 evels and compared the expected and observed prevalence rates to test if the coexistence of the DBM c

262 Delirium prevalence rates varied significantly with reason for IC

263 are common in children and adolescents, with prevalence rates varying from 6 to 20%.

264 The prevalence rate was 19.8%.

265 The commercial/Medicare 2006 CKD prevalence rate was 36.1/1,000 in CHB patients and 10.2/

266 ere in the PICU for 6 or more days, delirium prevalence rate was 38%.

267 The gender-adjusted prevalence rate was 5.8%.

268 ies; for late AMD, 20% of the variability in prevalence rates was explained by differences in age and

269 Based on reported prevalence rates, we calculated a sibling recurrence ris

270 ity/positive predictive values based on a 5% prevalence rate were 99.6%/92.8%, 99.6%/90.6%, 98.0%/71.

271 Prevalence rates were 12.2% (95% CI, 10.2-14.1) for any

272 71.2% male, 62.0% white), tardive dyskinesia prevalence rates were 13.1% for second-generation antips

273 The prevalence rates were 15.6% to 41.8% for anxiety disorde

274 M. genitalium prevalence rates were 16.1% for females and 17.2% for ma

275 The crude and age-adjusted point prevalence rates were 2.00 and 4.12, respectively.

276 STDR and OSA prevalence rates were 36.1% and 63.9%, respectively.

277 nce rates were 82.8% and 65.1%, and antibody prevalence rates were 73.1% and 62.1%.

278 chocerciasis was endemic, microfilariae (MF) prevalence rates were 82.8% and 65.1%, and antibody prev

279 Age-standardized prevalence rates were calculated for 3 dyslipidemia subt

280 Incidence and prevalence rates were calculated for nonexudative and ex

281 Prevalence rates were calculated, and odds ratios were a

282 Crude and age-adjusted incidence and prevalence rates were calculated.

283 Simple prevalence rates were calculated.

284 Antibody prevalence rates were close to zero among subjects born

285 Although overall prevalence rates were comparable between the two methods

286 MF and antibody prevalence rates were correlated (Spearman's r=0.815; P<

287 Twelve-month prevalence rates were established using the Composite In

288 Incidence and prevalence rates were estimated and were age-and sex-adj

289 National prevalence rates were estimated by using a population-we

290 Prevalence rates were estimated using data from three co

291 ramatically over the past number of decades, prevalence rates were generally highest among Whites and

292 the age-, sex-, and race/ethnicity-specific prevalence rates were multiplied by the US Census estima

293 years ago very high multiple sclerosis (MS) prevalence rates were recorded in northern Scotland.

294 Prevalence rates were weighted to adjust for the complex

295 f this study was to explore the reduction in prevalence rates when distress is considered in the diag

296 in developed countries, such as the US, SV40 prevalence rates will be generally very low.

297 Prevalence rates with and without subjective distress el

298 We were unable to compare prevalence rates with data prior to 2010, as the populat

299 ing more than 550,000 students were used and prevalence rates (%) with 95% CIs were calculated.

300 contributing to some of the highest national prevalence rates worldwide.